Novo-Holdings-As

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
31
Total Value
1314623581
Accession Number
0000950123-25-005753
Form Type
13F-HR
Manager Name
Novo-Holdings-As
Data Enrichment
97% identified
30 identified1 unidentified

Holdings

31 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
922908769
Shares:1.0M
Value:$285.4M
BROOKFIELD Corp /ON/
Shares:2.3M
Value:$122.2M
Edgewise Therapeutics, Inc.
Shares:5.3M
Value:$117.7M
ASML HOLDING NV
Shares:165.8K
Value:$109.9M
Salesforce, Inc.
Shares:272.8K
Value:$73.2M
Mirum Pharmaceuticals, Inc.
Shares:1.5M
Value:$67.6M
INSMED Inc
Shares:724.7K
Value:$55.3M
RECURSION PHARMACEUTICALS, INC.
Shares:9.7M
Value:$51.1M
Alibaba Group Holding Ltd
Shares:372.3K
Value:$49.2M
Crinetics Pharmaceuticals, Inc.
Shares:1.3M
Value:$42.8M
BIOMARIN PHARMACEUTICAL INC
Shares:490.0K
Value:$34.6M
ArriVent BioPharma, Inc.
Shares:1.9M
Value:$34.6M
Vaxcyte, Inc.
Shares:915.0K
Value:$34.6M
Merus N.V.
Shares:789.1K
Value:$33.2M
Viridian Therapeutics, Inc.\DE
Shares:2.3M
Value:$30.3M
Pharvaris N.V.
Shares:1.7M
Value:$27.1M
AMICUS THERAPEUTICS, INC.
Shares:2.8M
Value:$22.4M
Celldex Therapeutics, Inc.
Shares:1.2M
Value:$21.8M
Blueprint Medicines Corp
Shares:228.8K
Value:$20.3M
Zenas BioPharma, Inc.
Shares:2.2M
Value:$17.5M